Inferior vena cava (IVC) filters are small, spider-like devices that are implanted in patients who are at risk for developing severe blood clots. These filters are designed to catch clots in the bloodstream and break them apart before they are allowed to migrate to another part of the body and cause a stroke, myocardial infarction, or pulmonary embolism. These retrievable filters were intended to be placed in the body for only a short amount of time while the patient is in immediate danger. However, several studies have found that a large number of patients have suffered from serious complications after the device was left in the body for an extended period of time. Many of these injured patients have filed claims in the IVC filter lawsuit, and many of these individual claims have been consolidated into multidistrict litigation (MDL) actions. Recently, plaintiffs who have brought claims against Cook Medical have agreed to schedule the first IVC filter bellwether trials in Indiana, which are expected to begin in September 2016.
National Legal News
- Shoulder Pain Pumps and Cartilage Damage – The Scientific Evidence
- Is Avandia Dangerous? What Consumers Should Know about Avandia and Heart Problems
- Four New Levaquin Suits Filed Over Tendon Rupture Risks
- The Dangers of Reglan – Are You At Risk?
- Hydroxycut Products Recalled; FDA Urges Consumers to Discontinue Use of the Diet Supplement
- Fentanyl Pain Patch Overdose Lawsuits
- FDA Imposes Urgent Safety Warnings on Fluoroquinolone Drugs Due to Tendon Risks
Invokana® belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are often recommended for patients with type 2 diabetes. These types of medications work by reducing the amount of glucose that is reabsorbed in the blood and increasing the amount of glucose that is excreted by the kidneys. When combined with a healthy diet and exercise, Invokana® is intended to help patients manage their condition and avoid dangerous fluctuations in their blood glucose levels. However, an increased incidence of potentially serious complications, such as diabetic ketoacidosis, kidney failure, and heart attacks, have caused many patients to file claims in the Invokana® lawsuit.